Major Depressive Disorder

Showing NaN - NaN of 66

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDD Trial in Worldwide (AZD6765 iv, Placebo)

Completed
  • Major Depressive Disorder
  • AZD6765 iv
  • Placebo
  • Chino, California
  • +43 more
Apr 10, 2017

MDD Trial in Mexico, United States (DVS SR)

Completed
  • Major Depressive Disorder
  • DVS SR
  • Dothan, Alabama
  • +34 more
Dec 16, 2016

MDD Trial in United States (LY2940094, Placebo)

Completed
  • Major Depressive Disorder
  • North Miami, Florida
  • +9 more
Feb 1, 2017

MDD Trial in United States (OPC-34712, Placebo, ADT)

Completed
  • Major Depressive Disorder
  • Arcadia, California
  • +49 more
Feb 2, 2016

MDD Trial in United States (ADT, OPC-34712)

Completed
  • Major Depressive Disorder
  • Arcadia, California
  • +31 more
Oct 6, 2015

MDD Trial in United States (OPC-34712, Placebo, ADT)

Completed
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +42 more
Sep 30, 2015

MDD Trial in Worldwide (Placebo, Vilazodone)

Completed
  • Major Depressive Disorder
  • Beverly Hills, California
  • +74 more
May 15, 2015

MDD Trial in United States (Vilazodone, Placebo to citalopram, Placebo to vilazodone)

Completed
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +53 more
Aug 6, 2014

MDD, Depression Trial in India, Puerto Rico, United States (TC-5214, Placebo)

Completed
  • Major Depressive Disorder
  • Depression
  • Birmingham, Alabama
  • +98 more
Mar 14, 2014

MDD Trial in United States (Dose-matched , Vilazodone)

Completed
  • Major Depressive Disorder
  • Beverly Hills, California
  • +13 more
Feb 21, 2014

MDD Trial in United States (Escitalopram)

Completed
  • Major Depressive Disorder
  • Dothan, Alabama
  • +15 more
Jan 31, 2014

MDD Trial in United States (Selegiline Transdermal System, Placebo)

Completed
  • Major Depressive Disorder
  • Selegiline Transdermal System
  • Placebo
  • Dothan, Alabama
  • +19 more
Dec 12, 2013

MDD Trial in United States (Aripiprazole+ ADT, Placebo+ ADT)

Completed
  • Major Depressive Disorder
  • Aripiprazole+ ADT
  • Placebo+ ADT
  • Birmingham, Alabama
  • +33 more
Nov 7, 2013

MDD Trial in United States (Antidepressant + Placebo, Antidepressant + Aripiprazole)

Completed
  • Major Depressive Disorder
  • Antidepressant + Placebo
  • Antidepressant + Aripiprazole
  • Beverly Hills, California
  • +27 more
Nov 22, 2013

MDD Trial in United States (Antidepressant + Placebo, Antidepressant + Aripiprazole)

Completed
  • Major Depressive Disorder
  • Antidepressant + Placebo
  • Antidepressant + Aripiprazole
  • Garden Grove, California
  • +19 more
Nov 22, 2013

MDD Trial in United States (RX-10100)

Completed
  • Major Depressive Disorder
  • Cerritos, California
  • +43 more
Nov 18, 2013

MDD Trial in United States (Antidepressant + Aripiprazole)

Completed
  • Major Depressive Disorder
  • Antidepressant + Aripiprazole
  • Mesa, Arizona
  • +57 more
Nov 7, 2013

MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)

Completed
  • Major Depressive Disorder
  • Levomilnacipran ER
  • Placebo
  • Birmingham, Alabama
  • +50 more
Aug 22, 2013

MDD Trial in United States (Levomilnacipran ER, Placebo)

Completed
  • Major Depressive Disorder
  • Levomilnacipran ER
  • Placebo
  • Phoenix, Arizona
  • +37 more
Aug 22, 2013

MDD Trial in United States (Levomilnacipran ER, Placebo)

Completed
  • Major Depressive Disorder
  • Levomilnacipran ER
  • Placebo
  • Scottsdale, Arizona
  • +24 more
Aug 22, 2013

Sleep Disorders, Obstructive Sleep Apnea, MDD Trial in United States (armodafinil, )

Completed
  • Sleep Disorders
  • +3 more
  • Jasper, Alabama
  • +61 more
Jul 12, 2013

MDD Trial in United States (Lurasidone 20 mg, Lurasidone 60 mg, Placebo)

Withdrawn
  • Major Depressive Disorder
  • Lurasidone 20 mg
  • +2 more
  • Birmingham, Alabama
  • +26 more
Dec 11, 2012

MDD Trial in United States (AZD2066, Placebo, Duloxetine)

Terminated
  • Major Depressive Disorder
  • Garden Grove, California
  • +12 more
Sep 27, 2012

MDD Trial in United States (F2695 SR)

Completed
  • Major Depressive Disorder
  • F2695 SR
  • Dothan, Alabama
  • +67 more
Aug 15, 2012

MDD Trial in Worldwide (Placebo, fluoxetine, duloxetine)

Completed
  • Major Depressive Disorder
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +55 more
Mar 26, 2012